Benvenue Medical’s Luna 3D Interbody Fusion System to Be Featured in Technology Innovation Session at NASS 2016

SANTA CLARA, Calif.–(BUSINESS WIRE)–Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, today announced key presentations and company events featuring the Luna^® 3D Multi-Expandable Interbody Fusion System and Kiva^® VCF Treatment System at the North American Spine Society (NASS) 31^st Annual Meeting taking place Oct. 26-29 in Boston.

Benvenue is one of eight companies selected to present in the Innovative Technology Presentations Session. Dr. Jeffrey Coe of the Silicon Valley Spine Institute (Campbell, California) will provide an overview of the Luna 3D system and discuss early clinical results in the presentation, “Multiexpandable Cage for Minimally Invasive Posterior Lumbar Interbody Fusion,” on Oct. 26 at 8:30 a.m. in room 209.

“The Luna 3D System further advances minimally invasive lumbar fusion surgical techniques,” said Dr. Coe. “An important advantage of Luna’s multi-expandable cage for fusion is that it allows us to restore disc height using a well-established posterior surgical approach while providing stable fixation via a larger construct that is more often achieved using an anterior approach. Early experience with the Luna interbody cage is demonstrating encouraging outcomes, including restoration of disc height, segmental lordosis and foraminal height, along with lack of subsidence and maintenance of sagittal correction. Importantly, these results are being achieved without nerve retraction injuries, which are which are a risk of posterior lumbar fusion.”

Data Presentations

• “Incidence of Serious Adverse Events Associated with Readmissions after Vertebral Augmentation Using an Expandable Implant: Follow-Up Analysis of KAST” (presentation #10) will be presented by Dr. Douglas Beall of Clinical Radiology of Oklahoma (Edmond, Oklahoma) on Oct. 26 at 10:47 a.m. in room 205A. The podium presentation will review serious adverse events requiring unplanned re-admission for patients who had vertebral augmentation using the Kiva VCF Treatment System as compared to balloon kyphoplasty.
• “Community Practice Experience with Subsequent Vertebral Compression Fractures During the Year after Vertebral Augmentation Using an Expandable Implant” (presentation #88) will be presented by Dr. Arthur McCain of Vascular and Interventional Radiology Associates of Central Georgia (Macon, Georgia) on Oct. 27 at 3:10 p.m. in The Learning Place, Green Theater Technical Exhibition, booth #1900. The poster reviews the rate of subsequent vertebral compression fractures in the year following vertebral augmentation with the Kiva VCF Treatment System.
• “Biomechanics of Expandable Lumbar Interbody Fusion Cage Deployed Through Transforaminal Approach” (ePoster #11) will be moderated by Dr. Avinash Patwardhan of Loyola University Medical Center Department of Orthopaedic Surgery (Maywood, Illinois). The poster highlights a novel posterior minimally invasive approach to safely access the lumbar disc without intrusion into the spinal canal by use of the Luna 3D interbody cage to restore disc height as a means to achieve indirect canal and foraminal decompression.

Benvenue is exhibiting at booth #1451, where it is hosting “Meet the Experts” sessions throughout the day on Oct. 26 and Oct. 27. The company is also sponsoring the following product demonstration labs in The Learning Place on the Convention Floor:

• “Luna 3D, the MULTI-Expandable Interbody Implant” on Oct. 26 at 2 p.m.
• “Luna 3D Expandable Interbody Fusion System Surgeon Training Lab” on Oct. 27 at 5 p.m.

About the Luna 3D Interbody Fusion System

The Luna 3D Interbody Fusion System is designed to provide one of the largest yet least invasive devices for posterior lumbar interbody spinal fusion. Cleared by the U.S. Food and Drug Administration in November 2014, the Luna 3D System is comprised of a PEEK implant designed to expand in multiple dimensions within the disc space, first in footprint and secondarily in height, allowing surgeons to effectively restore height via a posterior approach while providing the stability of a larger construct more often associated with an anterior approach. After a discectomy is performed, the Luna 3D Implant is delivered through a small diameter cannula into the disc space. After expanding its footprint, it is then expanded in height with the insertion of a middle section. When the cannula is removed, bone graft is placed in the middle of the implant and the implant is locked in place with a locking wire.

About the Kiva VCF Treatment System

The Kiva VCF Treatment System provides a new implant-based approach to vertebral augmentation in the treatment of painful VCFs. Kiva was recently launched in the U.S. and it is commercially available in Europe. Kiva has been shown, in at least three comparative studies with a total of more than 500 patients, to meet or exceed the performance of balloon kyphoplasty, the standard of care. Kiva is indicated for the reduction and treatment of spine fractures in the thoracic and/or lumbar spine from T6-L5. It is intended to be used in combination with the Benvenue Vertebral Augmentation Cement Kit.

About Benvenue Medical, Inc.

Founded in 2004, Benvenue Medical, Inc. provides next generation minimally invasive systems for spine repair that combine expandable implants with novel delivery instruments to provide enduring functional benefits for patients. The company is privately held and funded by DeNovo Ventures, Domain Associates, Esquilime Partners, InterWest Partners, Technology Partners and Versant Ventures. Its first products are designed for the treatment of vertebral compression fractures and degenerative disc disease, which have combined revenues of $9 billion globally. For more information, visit www.benvenuemedical.com.